Xcout Intel
Spiral Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Spiral Therapeutics among biotechnology companies — ranked by similarity to what Spiral Therapeutics actually does, not by market-cap band.
Subscribe to see Spiral Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Spiral Therapeutics
Spiral Therapeutics Inc. is a clinical-stage pharmaceutical company based in South San Francisco, California, focused on delivering targeted therapies for inner ear conditions.
Spiral Therapeutics at a glance
Spiral Therapeutics is a biotechnology company headquartered in United States. It has raised at least $46.4M across the 3 funding rounds on record. Its most recent funding round, Series B, raised $27M in April 2026. Xcout tracks 16 named people at Spiral Therapeutics, including Kyle Peterson (CHIEF FINANCIAL OFFICER).
Spiral Therapeutics leadership
- Kyle PetersonCHIEF FINANCIAL OFFICER
- Charles Limb, MDCHIEF MEDICAL OFFICER
- Eugene de Juan, MDEXECUTIVE CHAIRMAN
- Hugo PerisFOUNDER & CEO
- Jeffrey Sharon, MDSVP CLINICAL SCIENCE
- Eugene de Juan, MDExecutive Officer
10 more named people on record for Spiral Therapeutics, with roles, board committees and tenure — see the full roster →
Spiral Therapeutics funding rounds
At least $46.4M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $27M | 6 named | |
| SEC Form D filing | $10.9M | — | |
| SEC Form D filing | $8.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Spiral Therapeutics competitors
Ranked by semantic similarity — how close each company is to Spiral Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Sensorion is a French biopharmaceutical company developing therapies for inner-ear disorders, including hearing loss and vestibular diseases. Its products are intended for patients with debilitating auditory and balance-related conditions, serving healthcare providers and the broader biopharmaceutical market.
Similar biotechnology company
Circle Pharma, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, harnessing macrocycles for drug development.
Similar biotechnology company
Switch Therapeutics Inc. is a biotechnology company headquartered in South San Francisco, California. Founded in 2020, the company develops RNAi therapies based on its proprietary technology.
Similar biotechnology company
Oricula Therapeutics LLC is a biotechnology company developing medications designed to prevent drug-induced hearing loss. Its lead product candidate, an oral medication called ORC-13661, aims to protect inner ear hair cells from the damaging side effects of aminoglycoside antibiotics.
Similar biotechnology company
Skylark Bio is a biotechnology company developing precision-targeted, locally delivered gene therapies to treat genetic hearing loss and other single-gene disorders. The company's platform aims to restore natural biological processes and hearing function, addressing conditions that affect children and individuals with genetic communication impairments.
Biotech
Marea Therapeutics is a biotechnology research company headquartered in South San Francisco, California. The company focuses on developing novel therapeutics within the biopharma sector.
Biotech
SonoThera, Inc. is a biotechnology company headquartered in South San Francisco, California, focused on developing genetic medicines and advancing the field of gene therapy.
Similar biotechnology company
RAPT Therapeutics is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The firm is driven by its mission to develop oral small molecule therapies to treat inflammatory and immunologic diseases.
Biotech
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Life Sciences
Cortexyme, Inc. is a biopharmaceutical company headquartered in South San Francisco, California, focused on discovering and developing therapeutics for major degenerative disorders.
Life Science
Acousia Therapeutics GmbH is a privately held biotechnology company founded in 2012 to develop therapeutics fighting hearing loss. Supported by a strong investor consortium, the company is based in Tübingen, Germany.
Similar biotechnology company
Neuron23 is a biotechnology company founded in 2018 that focuses on developing precision therapeutics for genetic diseases. Headquartered in South San Francisco, California, the company relies on a team of scientific experts and entrepreneurs.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Spiral Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Spiral Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →